New injection relieves symptoms of Crohn's disease


UCB's Cimzia has received Food & Drug Administration approval for treating Crohn's disease.

Crohn’s disease patients have a new monthly treatment option open to them. It’s UCB’s UCB claims Cimzia is the first and only PEGylated anti-tumor necrosis factor alpha antibody indicated for this

Related Videos
fake news misinformation | Image Credit: Bits and Splits -
© 2024 MJH Life Sciences

All rights reserved.